Holger N Lode Advances in Neuroblastoma Research Congress 2016

Abstracts this author is presenting:

• Killer-cell Ig-like receptor (KIR) haplotypes and Fcγ-receptor polymorphisms correlate with antibody-dependent cell-mediated cytotoxicity levels and survival of high-risk relapsed/refractory neuroblastoma patients treated by long-term infusion of anti-GD₂ antibody ch14.18/CHO in combination with interleukin-2 (IL-2). — Parallel 14 Clinical Awards Session
• Phase II clinical trial with long-term infusion of anti-GD₂ antibody ch14.18/CHO in combination with interleukin-2 (IL2) showed clinical efficacy and improved toxicity in patients with high risk neuroblastoma. — Parallel 12 Immunotherapy and Early Phase Trials